Sign In
Buy MRNA
$51.59
+2.53 (+5.16%)
At Close: Jun 04, 2026
Moderna names PerkinElmer exec as new CFO
08:19am, Wednesday, 17'th Aug 2022
Moderna Inc on Wednesday named former PerkinElmer executive James Mock as the company's chief financial officer, effective Sept. 6.
Moderna CFO David Meline to retire, to be succeed by PerkinElmer's James Mock
08:16am, Wednesday, 17'th Aug 2022
Moderna Inc. MRNA, -4.99% said Wednesday that Chief Financial Officer David Meline will retire, effective Sept. 6. Moderna shares fell 0.6% in premarket trading.
Buy the dips, says Virtus' Joe Terranova
08:19pm, Tuesday, 16'th Aug 2022
Joe Terranova, Virtus Investment Partners, joins 'Closing Bell: Overtime' to discuss the markets.
Novavax (NVAX) Seeks FDA Authorization for COVID-19 Booster Dose
04:32pm, Tuesday, 16'th Aug 2022 Zacks Investment Research
Novavax (NVAX) seeks label expansion from the FDA for its COVID-19 vaccine as a booster dose in adults. The vaccine is authorized as a primary two-dose regimen in adults.
Why Moderna Stock Is Sliding Today
04:05pm, Tuesday, 16'th Aug 2022 The Motley Fool
There wasn't any negative news from the vaccine maker.
Why Moderna Stock Is Sliding Today
12:05pm, Tuesday, 16'th Aug 2022
There wasn't any negative news from the vaccine maker.
U.K. regulator is first to authorize Moderna's bivalent COVID booster for 18-and-older population
11:22am, Tuesday, 16'th Aug 2022 MarketWatch
The U.K. regulator has become the first to authorize Moderna's bivalent COVID vaccine booster for use in adults aged 18 and older.
Why Moderna Stock Climbed Today
10:11pm, Monday, 15'th Aug 2022 The Motley Fool
The biotech's COVID-19 vaccine sales could be about to receive a boost.
Is Moderna Stock a Buy Now After the U.K.'s Omicron Vaccine Approval?
06:59pm, Monday, 15'th Aug 2022 The Motley Fool
The pioneering COVID-19 fighter claims another victory, and shareholders are celebrating.
Why Moderna Stock Climbed Today
06:11pm, Monday, 15'th Aug 2022
The biotech's COVID-19 vaccine sales could be about to receive a boost.
Is Moderna Preparing To Soar 20% And Tackle This Big Level? What To Watch On The Weekly Chart
04:43pm, Monday, 15'th Aug 2022 Benzinga
Moderna, Inc (NASDAQ: MRNA) spiked up almost 5% off Friday’s closing price at one point on Monday, before hitting a resistance level at the $179 level and running into a group of sellers.
The phar
Three Stock Lunch: Disney, Moderna and Exxon Mobil
03:30pm, Monday, 15'th Aug 2022
Delano Saporu, New Street Advisors CEO, joins 'Power Lunch' to discuss Saporu's investing take on three stocks: Disney, Moderna and Exxon Mobil. For access to live and exclusive video from CNBC subscr
Is Moderna Stock a Buy Now After the U.K.'s Omicron Vaccine Approval?
02:59pm, Monday, 15'th Aug 2022
The pioneering COVID-19 fighter claims another victory, and shareholders are celebrating.
Is Moderna Preparing To Soar 20% And Tackle This Big Level? What To Watch On The Weekly Chart
12:43pm, Monday, 15'th Aug 2022
Moderna, Inc (NASDAQ: MRNA) spiked up almost 5% off Friday's closing price at one point on Monday, before hitting a resistance level at the $179 level and running into a group of sellers.
Novavax's (NVAX) COVID Vaccine Aids Growth, Overdependence Ails
12:39pm, Monday, 15'th Aug 2022 Zacks Investment Research
Currently, Novavax (NVAX) has only one marketed product in its portfolio, its protein-based COVID-19 vaccine. However, it is lagging in competition behind mRNA-based vaccines.
